new-clinical-trial-aims-to-treat-depression-in-people-with-parkinson’s-disease

Experts at Yale and UCSF are initiating an innovative dual-site clinical study exploring psilocybin, a hallucinogenic substance, as a possible remedy for depression associated with Parkinson’s.


Leave a Reply

Your email address will not be published. Required fields are marked *

Share This